"O IBPClin um Centro de Pesquisa Clínica, dedicado à condução de grandes estudos multicêntricos para desenvolvimento de novos medicamentos para a indústria farmacêutica."

During the past decade, CCBR - Centro de Pesquisas e Analises Clinicas LTDA conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CCBR - Centro de Pesquisas e Analises Clinicas LTDA" are "Cardiovascular Disease" (1 trials), "Chronic Pain" (1 trials), "Osteoarthritis, Hip" (1 trials) and "Osteoarthritis, Knee" (1 trials). Many other conditions were trialed in "CCBR - Centro de Pesquisas e Analises Clinicas LTDA" in a lesser frequency.

Most popular intervention types in "CCBR - Centro de Pesquisas e Analises Clinicas LTDA" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "NSAID" (1 trials), "Placebo" (1 trials), "Tanezumab 2.5 mg" (1 trials), "Tanezumab 5 mg" (1 trials) and "bococizumab (PF-04950615)" (1 trials). Other intervention names were less common.

The vast majority of trials in "CCBR - Centro de Pesquisas e Analises Clinicas LTDA" are 2 trials for "All" genders.

Currently, there are NaN active trials in "CCBR - Centro de Pesquisas e Analises Clinicas LTDA". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in CCBR - Centro de Pesquisas e Analises Clinicas LTDA, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in CCBR - Centro de Pesquisas e Analises Clinicas LTDA, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".